DCM Shriram FY26 Revenue ₹13,538 Crore, PAT ₹856 Crore
DCM Shriram reported FY26 Net Revenue of ₹13,538 crore (up 12%) and PAT of ₹856 crore (up 42%). The Chemicals business revenue grew 31% to ₹4,651 crore. Fenesta Building Systems revenue increased 28% to ₹1,112 crore. The company announced a final dividend of 200%.
The announcement includes full-year financial results, detailing revenue and profit growth across major business segments, along with strategic investment updates and a significant dividend declaration, all of which are material information for investors.
The company reported significant year-on-year growth in revenue and profit after tax, driven by strong performance in its Chemicals business and positive contributions from other segments. The company also announced a substantial dividend payout.
DCM Shriram Limited has announced its audited financial results for the year ended March 31, 2026. The company reported a consolidated Net Revenue of ₹13,538 crore, an increase of 12% compared to ₹12,077 crore in the previous fiscal year. Profit After Tax (PAT) stood at ₹856 crore, marking a significant 42% rise from ₹604 crore in FY2025.
The company's Chemicals and Vinyl business demonstrated robust growth, with revenues up 31% to ₹4,651 crore and PBDIT increasing by 39% to ₹843 crore. This performance was driven by strong volume growth in caustic soda and the progressive ramp-up of expansion and downstream integration. The Epichlorohydrin (ECH) facility was fully commissioned in April 2026, contributing positively. The Sugar and Ethanol business saw a revenue decline of 2% to ₹3,770 crore, with PBDIT increasing by 3% to ₹438 crore. Margins in the sugar business were stable, while ethanol margins improved.
Fenesta Building Systems reported a 28% increase in revenue to ₹1,112 crore, with PBDIT down 5% to ₹116 crore due to increased fixed costs for scaling the business and new product platforms. Shriram Farm Solutions saw an 18% revenue growth to ₹1,689 crore, with PBDIT up 5% to ₹296 crore. The Fertilizer segment's revenue remained stable at ₹1,445 crore, while PBDIT increased by 25% to ₹105 crore. Bioseed's revenue grew by 3% to ₹666 crore, with PBDIT down 14% to ₹57 crore.
In terms of investments, the company completed several key projects, including an Epichlorohydrin (ECH) plant and an acquisition of HSCL for advanced materials. Future investments include expansions in Fenesta's aluminum extrusion plant and additional renewable energy capacity. The company also announced a final dividend of 200%, amounting to ₹62.38 crore, on a total of 560% for the year (₹174.66 crore).
What to do with a filing like this
DCM Shriram Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Limited. Read the original for the full detail.